Orexin-2 Receptor Agonist E2086 to Be Tested in Narcolepsy Patients
Eisai Inc is set to begin enrolling patients for a clinical trial to test the effectiveness and safety of E2086 for narcolepsy type 1.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
